INTERNATIONAL & USA PRESS INQUIRIES
Please contact David Fraser for international media inquiries
July 20, 2023
Philip Morris International Reports 2023 Second-Quarter and First-Half Results
downloadDelivered 2023 Second-Quarter Reported Diluted EPS of
2023 SECOND-QUARTER HIGHLIGHTS
|
|
Second-Quarter |
||||||
|
|
|
|
Change vs. Q2 2022 |
||||
|
|
Amount |
|
Reported |
|
Adjusted |
||
Total Cig. & HTU Shipment Volume (units bn) |
|
188.4 |
|
3.3% |
|
|
|
|
HTU Shipment Volume (units bn) |
|
31.4 |
|
26.6% |
|
|
|
|
Oral Product Shipment Volume (mn cans) (1) |
|
197.4 |
|
+100% |
|
13.8% |
(2) |
|
Net Revenues ($ bn) |
|
|
|
14.5% |
|
10.5% |
(3) |
|
Smoke-Free Product Net Revenues ($ bn) |
|
|
|
34.1% |
|
17.7% |
(3) |
|
-% of Total Net Revenues |
|
35.4% |
|
5.2pp |
|
|
|
|
Operating Income ($ bn) |
|
|
|
(16.0)% |
|
6.9% |
(3) |
|
Diluted Earnings per Share |
|
|
|
(29.4)% |
|
|
|
|
Adjusted Diluted Earnings per Share |
|
|
|
|
|
16.9% |
(4) |
|
(1) Excludes snuff, snuff leaf and |
||||||||
(2) On a pro forma basis (including |
||||||||
(3) On an organic basis |
||||||||
(4) Excluding currency |
- Reported net revenues up by 19.0%, excluding currency
- Pro forma (including
Swedish Match in all periods) adjusted net revenue growth of 11.1%, excluding currency - Combustible tobacco net revenue growth of 6.0%; growth of 7.4% on an organic basis, driven by pricing of over 9%
- Market share for HTUs in IQOS markets up by 1.6 points to 9.2%
- Adjusted in-market sales volume for HTUs, which excludes the net favorable impact of estimated distributor and wholesaler inventory movements, up by an estimated 16%
- Total IQOS users at quarter-end estimated at approximately 27.2 million (up by 1.4 million versus
March 2023 ), of which approximately 19.4 million had switched to IQOS and stopped smoking - ZYN nicotine pouch (NP) shipment volume in the
U.S. of 89.9 million cans, representing growth of 53.1% versus second-quarter 2022Swedish Match shipments of 58.7 million cans - Declared regular quarterly dividend of
$1.27 per share, or an annualized rate of$5.08 per share
"Our strong business momentum continued with an excellent second quarter," said
"The outstanding performance of
"Our strong fundamentals give us further confidence as we enter the second half of the year, particularly as certain inflationary and operational pressures ease. We are therefore raising our full-year 2023 forecast for organic net revenue growth to a range of 7.5% to 8.5% and currency-neutral adjusted diluted EPS growth to a range of 8.0% to 9.5%."
"As we look to the longer term, we are complementing our smoke-free transformation with the further development of our wellness and healthcare business. While we have experienced some initial headwinds, we remain committed to wellness and healthcare, with a focused strategy on several attractive growth opportunities."
2023 SECOND-QUARTER SUMMARY
Net revenues increased by 10.5% on an organic basis, driven by total cigarette and HTU shipment volume growth of 3.3% (reflecting growth of 26.6% for HTUs and a decline of 0.4% for cigarettes), the favorable product mix impact associated with the increasing proportion of smoke-free products within PMI's product portfolio, and combustible tobacco pricing in excess of 9%.
HTU shipment volume in the quarter benefited from the favorable net estimated impact of both distributor and wholesaler inventory movements. Excluding these movements, adjusted in-market sales volume for HTUs increased by an estimated 16%, reflecting continued strong IQOS momentum.
While excluded from organic financial performance in the quarter,
Adjusted operating income increased by 6.9% on an organic basis, despite global inflationary pressures related to direct materials, tobacco leaf, energy and wages. Adjusted operating income margin of 39.4% increased by 2.1 points sequentially versus the first quarter.
Adjusted diluted EPS of
|
|
Second-Quarter |
|||||||||||||
|
|
2023 |
|
2022 |
|
Currency |
|
Var. excl. |
|||||||
Reported Diluted EPS |
|
$ |
1.01 |
|
$ |
1.43 |
|
$ |
(0.13 |
) |
(20.3 |
)% |
|||
Tax benefit associated with |
|
|
(0.01 |
) |
|
— |
|
|
|
||||||
Impairment of goodwill and other intangibles |
|
|
0.44 |
|
|
— |
|
|
|
||||||
Amortization of intangibles |
|
|
0.04 |
|
|
0.02 |
|
|
|
||||||
Charges related to the war in |
|
|
— |
|
|
0.04 |
|
|
|
||||||
Costs associated with |
|
|
— |
|
|
0.02 |
|
|
|
||||||
|
|
|
0.11 |
|
|
— |
|
|
|
||||||
Fair value adjustment for equity security investments |
|
|
0.01 |
|
|
— |
|
|
|
||||||
Tax items |
|
|
— |
|
|
(0.03 |
) |
|
|
||||||
Adjusted Diluted EPS |
|
$ |
1.60 |
|
$ |
1.48 |
|
$ |
(0.13 |
) |
16.9 |
% |
2023 FULL-YEAR FORECAST
|
Full-Year |
|||||||||
|
2023 Forecast |
|
2022 |
|
Growth |
|||||
|
|
|
|
|
|
|
|
|
|
|
Reported Diluted EPS |
|
- |
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
Asset impairment and exit costs |
0.06 |
|
— |
|
|
|
|
|||
Termination of distribution arrangement in the |
0.04 |
|
— |
|
|
|
|
|||
Tax benefit associated with |
(0.06) |
|
(0.13) |
|
|
|
|
|||
Impairment of goodwill and other intangibles |
0.44 |
|
0.06 |
|
|
|
|
|||
Amortization of intangibles |
0.16 |
|
0.09 |
|
|
|
|
|||
Costs associated with |
— |
|
0.06 |
|
|
|
|
|||
Charges related to the war in |
— |
|
0.08 |
|
|
|
|
|||
|
0.01 |
|
0.06 |
|
|
|
|
|||
|
0.11 |
|
|
|
|
|
|
|||
Fair value adj. for equity security investments |
0.01 |
|
(0.02) |
|
|
|
|
|||
Tax items |
— |
|
(0.03) |
|
|
|
|
|||
Total Adjustments |
0.77 |
|
0.17 |
|
|
|
|
|||
Adjusted Diluted EPS |
|
- |
|
|
|
|
|
|
|
|
Less: Currency |
(0.33) |
|
|
|
|
|
|
|||
Adjusted Diluted EPS, excluding currency |
|
- |
|
|
|
|
8.0% |
- |
9.5% |
Reported diluted EPS is forecast to be in a range of
The company's forecast for adjusted diluted EPS growth, excluding currency, represents an increase compared to its
2023 Full-Year Forecast Assumptions
This forecast assumes:
- An estimated total international industry volume decline for cigarettes and HTUs, excluding
China and theU.S. , of 0.5% to 1.5%; - Total cigarette and HTU shipment volume growth for PMI of up to +1%;
- HTU shipment volume of 125 to 130 billion units, broadly in line with anticipated adjusted in-market sales volume and reflecting an acceleration in growth versus 2022;
- A cigarette shipment volume decline of approximately 1.5% to 2.5%;
- Net revenue growth of approximately 7.5% to 8.5% on an organic basis;
- Strong full-year performance for Swedish Match’s existing operations, underpinned by strong shipment volume growth for ZYN in the
U.S. ; - An adjusted operating income margin decline of 50 to 150 basis points on an organic basis, with the decline likely toward the upper (150 basis point) end of the range, notably due to technical factors;
- Incremental investments to drive future growth, including the commercialization of ILUMA and around
$150 million with a broadly even split between theU.S. and the Wellness and Healthcare segment; - Wellness and Healthcare segment net revenues of around
$300 million (including smoking cessation products), with an adjusted operating loss of around$150 million , primarily due to investments in research and development; - No contribution from any potential favorable court ruling related to the legality of a supplemental tax surcharge on HTUs in
Germany , which went into effect in 2022 (see PMI's first-quarter 2023 press release fromApril 20, 2023 , for additional detail). PMI expects to have greater visibility on the likely outcome toward the end of this year; - The contribution of the company's operations in
Russia andUkraine for the entire year; - Full-year amortization and impairment of acquired intangibles of
$0.60 per share, which includes amortization related to theSwedish Match acquisition based on preliminary purchase price allocation that may be subject to change; - A full year’s net positive earnings contribution from
Swedish Match including related interest expense, withSwedish Match included in PMI's organic performance as ofNovember 11, 2023 ; - Net financing costs of around
$1.2 billion ; - An effective tax rate, excluding discrete tax events, of approximately 20.5% to 21.5%;
- Operating cash flow of
$10 to$11 billion at prevailing exchange rates, subject to year-end working capital requirements; - Capital expenditures of approximately
$1.3 billion , partly reflecting increased investments behind smoke-free product manufacturing capacity, including for ILUMA consumables andSwedish Match's portfolio; - No share repurchases in 2023;
- Third-quarter adjusted diluted EPS in a range of
$1.60 to$1.65 , including an unfavorable currency impact, at prevailing exchange rates, of$0.06 per share, notably reflecting HTU shipment volume of around 31 to 33 billion units and high-single-digit organic top-line growth; - Strong second-half 2023 organic adjusted operating income growth that supports second-half adjusted operating income margin expansion on the same basis, with notably strong performance in the fourth quarter.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.
Sale of Swedish Match Subsidiary
As previously disclosed, under the EU Merger Regulation, approval by the
War in
In
PMI is continuously assessing the evolving situation in
Scientific Update
Regulatory Science Update
PMI has specifically designed a product assessment program to deliver the pre-market scientific evidence that governmental authorities need in order to understand and assess novel tobacco products with the potential to reduce the risk of disease.
PMI received Premarket Tobacco Product Application (PMTA) authorizations for the IQOS Tobacco Heating System, blade versions 2.4 and 3.0, from the
PMI is on track for its IQOS ILUMA PMTA submission in the fourth quarter of 2023 to seek market authorization in the
Inhaled Aspirin Product Clinical Trial Results
During the second quarter, the company received its first clinical trial results for an inhalable aspirin product being developed by its Wellness and Healthcare business. While it was observed that the experimental product had a rapid onset of effect, which is the key medical advantage sought, there was significant variability in inhaled dose among subjects. The study was therefore deemed unsuccessful and, as a result, product design improvements are required. The company had planned to file a new drug application for this product with the FDA later this year. However, additional time is now required to evaluate design improvements.
Other Scientific Matters
Between 2020 and 2023, PMI conducted time trend analysis studies (TTA Studies), including two in
Scientific Evidence for Tobacco Harm Reduction
The totality of the evidence to date on PMI's smoke-free products overwhelmingly supports their role in tobacco harm reduction. PMI’s scientific program has yielded over 500 scientific publications in peer-reviewed journals, including 14 in 2023.
PMI has a robust roadmap in place for future scientific studies, including post-market studies, and plans to elaborate further on these programs during the company's Investor Day on
Wellness and Healthcare Reporting Segment Asset Impairment Charge
During the second quarter of 2023, PMI completed its annual review of goodwill and non-amortizable intangible assets for potential impairment. Based on this review, it was determined that the estimated fair value of the Wellness and Healthcare reporting segment was below its carrying value, primarily reflecting the impact of two factors:
- The unsuccessful clinical trial results for the company's inhalable aspirin product discussed above, given the additional time now required to evaluate design improvements and the corresponding less certain outcome.
- Slower-than-anticipated development of the contract development and manufacturing organization (CDMO) business, including challenges associated with increased cost related to certain key products.
Consequently, PMI recorded a total impairment charge in the Wellness and Healthcare segment of
PMI remains committed to developing its Wellness and Healthcare business and continues to see attractive growth potential -- leveraging its unique and enabling R&D capabilities -- in areas such as inhalable drugs, nicotine-replacement therapy (NRT), and consumer wellness products, including non-recreational cannabinoids in line with applicable regulatory requirements. The company does, however, expect the aforementioned factors to postpone its 2025 ambition to reach over
Further detail on the company's Wellness and Healthcare business will be presented at PMI's 2023 Investor Day on
South Korea Indirect Tax Charge
On
As a result of the ruling, PMI management concluded that an adverse outcome is probable. Consequently, PMI recorded a non-cash pre-tax charge of
Conference Call
A conference call hosted by
TOTAL MARKET, CONSOLIDATED SHIPMENT VOLUME & MARKET SHARE
Total Market Volume
Second-Quarter
Estimated international industry volume (excluding
Six Months Year-to-Date
Estimated international industry volume (excluding
Consolidated Shipment Volume
PMI Cigarettes and HTUs |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
157,010 |
157,678 |
(0.4)% |
300,718 |
305,916 |
(1.7)% |
||||||
Heated Tobacco Units |
31,424 |
24,821 |
26.6% |
58,820 |
49,640 |
18.5% |
||||||
Total Cigarettes and HTUs |
188,434 |
182,499 |
3.3% |
359,538 |
355,556 |
1.1% |
PMI Oral Products (1) |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million cans) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Nicotine Pouches |
99.5 |
0.9 |
+100% |
180.7 |
1.9 |
+100% |
||||||
Snus |
62.6 |
5.1 |
+100% |
118.2 |
7.6 |
+100% |
||||||
Moist Snuff |
34.1 |
— |
—% |
69.3 |
— |
—% |
||||||
Other |
1.2 |
— |
—% |
2.5 |
— |
—% |
||||||
Total Oral Products |
197.4 |
6.0 |
+100% |
370.7 |
9.5 |
+100% |
||||||
(1) Excluding snuff, snuff leaf and |
||||||||||||
Note: Sum may not foot due to roundings. |
Second-Quarter
PMI's total cigarette and HTU shipment volume increased by 3.3%, reflecting a 26.6% increase in HTU shipments across all regions, partly offset by a 0.4% decline in cigarette shipments (due to the
PMI’s total oral product shipment volume increased by +100%, driven by the
Impact of Inventory Movements
Excluding the net favorable impact of estimated distributor inventory movements (primarily driven by HTUs), PMI’s total in-market sales for cigarettes and HTUs increased by 2.2%, reflecting 17.0% growth for HTUs (or 15.5% on an adjusted basis), partly offset by a decline of 0.2% for cigarettes. The net favorable impact of estimated distributor inventory movements for HTUs was driven primarily by
Six Months Year-to-Date
PMI's total cigarette and HTU shipment volume increased by 1.1%, reflecting an 18.5% increase in HTU shipments across all regions, partly offset by a 1.7% decline in cigarette shipments (mainly due to the
PMI’s total oral product shipment volume increased by +100%, driven by the
Impact of Inventory Movements
The net impact of estimated distributor inventory movements on PMI's total cigarette and HTU shipment volume was immaterial.
International Share of Market - Cigarettes and HTUs
|
Second-Quarter |
Six Months Year-to-Date |
||||||||||
2023 |
|
2022 |
|
Change |
|
2023 |
|
2022 |
|
Change |
||
|
|
|
|
|
|
|
||||||
Total International Market Share (1) |
28.5% |
27.4% |
1.1 |
27.9% |
27.4% |
0.5 |
||||||
Cigarettes |
23.9% |
23.5% |
0.4 |
23.3% |
23.4% |
(0.1) |
||||||
HTU |
4.6% |
3.9% |
0.7 |
4.6% |
4.0% |
0.6 |
||||||
|
|
|
|
|
|
|
||||||
Cigarette over Cigarette Market Share (2) |
25.5% |
24.8% |
0.7 |
24.8% |
24.7% |
0.1 |
(1) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding |
(2) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding |
CONSOLIDATED FINANCIAL SUMMARY
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net Revenues |
|
$ |
8,967 |
|
$ |
7,832 |
|
|
14.5 |
% |
10.5 |
% |
|
1,135 |
|
(351 |
) |
665 |
|
459 |
390 |
|
(28 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Cost of Sales (1) |
|
|
(3,228 |
) |
|
(2,648 |
) |
|
(21.9 |
)% |
(16.2 |
)% |
|
(580 |
) |
85 |
|
(235 |
) |
— |
(263 |
) |
(167 |
) |
|||||||
Marketing, Administration and Research Costs (2) |
|
|
(3,173 |
) |
|
(2,128 |
) |
|
(49.1 |
)% |
(43.2 |
)% |
|
(1,045 |
) |
40 |
|
(166 |
) |
— |
— |
|
(919 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Operating Income |
|
$ |
2,566 |
|
$ |
3,056 |
|
|
(16.0 |
)% |
(17.3 |
)% |
|
(490 |
) |
(226 |
) |
264 |
|
459 |
127 |
|
(1,114 |
) |
|||||||
Impairment of |
|
|
(680 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(680 |
) |
— |
|
— |
|
— |
— |
|
(680 |
) |
|||||||
Amortization of Intangibles |
|
|
(82 |
) |
|
(36 |
) |
|
-(100 |
)% |
8.3 |
% |
|
(46 |
) |
— |
|
(49 |
) |
— |
— |
|
3 |
|
|||||||
Charges related to the war in |
|
|
— |
|
|
(80 |
) |
|
+100 |
% |
+100 |
% |
|
80 |
|
— |
|
— |
|
— |
— |
|
80 |
|
|||||||
Costs associated with |
|
|
— |
|
|
(52 |
) |
|
+100 |
% |
+100 |
% |
|
52 |
|
— |
|
— |
|
— |
— |
|
52 |
|
|||||||
South Korea Indirect Tax Charge |
|
|
(204 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(204 |
) |
— |
|
— |
|
— |
— |
|
(204 |
) |
|||||||
Adjusted Operating Income |
|
$ |
3,532 |
|
$ |
3,224 |
|
|
9.6 |
% |
6.9 |
% |
|
308 |
|
(226 |
) |
313 |
|
459 |
127 |
|
(365 |
) |
|||||||
Adjusted Operating Income Margin |
|
|
39.4 |
% |
|
41.2 |
% |
|
(1.8 |
)pp |
(1.4 |
)pp |
|
|
|
|
|
|
|
||||||||||||
(1) Includes |
|||||||||||||||||||||||||||||||
(2) Includes |
Net revenues increased by 10.5% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing, partly offset by lower HTU (net) pricing; and favorable volume/mix, mainly driven by higher HTU volume and favorable cigarette mix, partially offset by lower cigarette volume and unfavorable HTU mix.
Adjusted operating income increased by 6.9% on an organic basis, mainly reflecting: the favorable pricing variance; and favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume, unfavorable HTU mix and unfavorable cigarette mix; partially offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages); and higher manufacturing costs (primarily due to inflationary impacts, notably related to direct materials, tobacco leaf and energy, partly offset by productivity).
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net Revenues |
|
$ |
16,986 |
|
$ |
15,578 |
|
|
9.0 |
% |
6.3 |
% |
|
1,408 |
|
(825 |
) |
1,246 |
|
796 |
349 |
|
(158 |
) |
|||||||
Termination of distribution arrangement in the |
|
|
(80 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(80 |
) |
— |
|
— |
|
— |
— |
|
(80 |
) |
|||||||
Adjusted Net Revenues |
|
$ |
17,066 |
|
$ |
15,578 |
|
|
9.6 |
% |
6.8 |
% |
|
1,488 |
|
(825 |
) |
1,246 |
|
796 |
349 |
|
(78 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Net Revenues |
|
$ |
16,986 |
|
$ |
15,578 |
|
|
9.0 |
% |
6.3 |
% |
|
1,408 |
|
(825 |
) |
1,246 |
|
796 |
349 |
|
(158 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Cost of Sales (1) |
|
|
(6,266 |
) |
|
(5,256 |
) |
|
(19.2 |
)% |
(14.0 |
)% |
|
(1,010 |
) |
201 |
|
(476 |
) |
— |
(453 |
) |
(282 |
) |
|||||||
Marketing, Administration and Research Costs (2) |
|
|
(5,423 |
) |
|
(3,968 |
) |
|
(36.7 |
)% |
(32.3 |
)% |
|
(1,455 |
) |
139 |
|
(313 |
) |
— |
— |
|
(1,281 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Operating Income |
|
$ |
5,297 |
|
$ |
6,354 |
|
|
(16.6 |
)% |
(16.2 |
)% |
|
(1,057 |
) |
(485 |
) |
457 |
|
796 |
(104 |
) |
(1,721 |
) |
|||||||
Asset Impairment & Exit Costs |
|
|
(109 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(109 |
) |
— |
|
— |
|
— |
— |
|
(109 |
) |
|||||||
Termination of distribution arrangement in the |
|
|
(80 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(80 |
) |
— |
|
— |
|
— |
— |
|
(80 |
) |
|||||||
Impairment of |
|
|
(680 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(680 |
) |
— |
|
— |
|
— |
— |
|
(670 |
) |
|||||||
Amortization of Intangibles |
|
|
(163 |
) |
|
(74 |
) |
|
-(100 |
)% |
13.5 |
% |
|
(89 |
) |
— |
|
(99 |
) |
— |
— |
|
10 |
|
|||||||
Charges related to the war in |
|
|
— |
|
|
(122 |
) |
|
+100 |
% |
+100 |
% |
|
122 |
|
— |
|
— |
|
— |
— |
|
122 |
|
|||||||
Costs associated with |
|
|
— |
|
|
(52 |
) |
|
+100 |
% |
+100 |
% |
|
52 |
|
— |
|
— |
|
— |
— |
|
52 |
|
|||||||
|
|
|
(18 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(18 |
) |
— |
|
(18 |
) |
— |
— |
|
— |
|
|||||||
South Korea Indirect Tax Charge |
|
|
(204 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(204 |
) |
— |
|
— |
|
— |
— |
|
(204 |
) |
|||||||
Adjusted Operating Income |
|
$ |
6,551 |
|
$ |
6,602 |
|
|
(0.8 |
)% |
(2.1 |
)% |
|
(51 |
) |
(485 |
) |
574 |
|
796 |
(104 |
) |
(832 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Adjusted Operating Income Margin |
|
|
38.4 |
% |
|
42.4 |
% |
|
(4.0 |
)pp |
(3.6 |
)pp |
|
|
|
|
|
|
|
||||||||||||
(1) Includes |
|||||||||||||||||||||||||||||||
(2) Includes |
|||||||||||||||||||||||||||||||
(3) Included in Net Revenues above. |
Adjusted net revenues increased by 6.8% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing, partly offset by lower HTU (net) pricing; and favorable volume/mix, mainly driven by higher HTU volume and favorable cigarette mix, partially offset by lower cigarette volume and unfavorable smoke-free product mix.
Adjusted operating income decreased by 2.1% on an organic basis, mainly reflecting: higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages, and lower commercial investments in the prior year period); higher manufacturing costs (primarily due to inflationary impacts, notably related to direct materials, tobacco leaf and energy, partly offset by productivity); and unfavorable volume/mix, mainly due to lower cigarette volume, as well as unfavorable HTU and cigarette mix, partly offset by higher HTU volume; partially offset by the favorable pricing variance.
Total Market, PMI Shipment & Market Share Commentaries
Second-Quarter
The estimated total market for cigarettes and HTUs in the Region decreased by 1.5% to 140.7 billion units, reflecting a 3.7% decline for cigarettes, partly offset by a 22.4% increase for HTUs. The decrease in the estimated total market was notably due to
Six Months Year-to-Date
The estimated total market for cigarettes and HTUs in the Region decreased by 0.5% to 266.2 billion units, reflecting a 2.3% decline for cigarettes, partly offset by a 18.1% increase for HTUs. The decrease in the estimated total market was notably due to
Europe Key Data |
Second-Quarter |
Six Months Year-to-Date |
||||||||||||||||
|
|
|
Change |
|
|
Change |
||||||||||||
|
2023 |
|
2022 |
|
% / pp |
2023 |
|
2022 |
|
% / pp |
||||||||
PMI Shipment Volume (million units) |
|
|
|
|
|
|
||||||||||||
Cigarettes |
43,741 |
|
45,166 |
|
(3.2 |
)% |
82,898 |
|
86,015 |
|
(3.6 |
)% |
||||||
Heated Tobacco Units |
11,705 |
|
10,542 |
|
11.0 |
% |
21,804 |
|
20,811 |
|
4.8 |
% |
||||||
Total |
55,446 |
|
55,708 |
|
(0.5 |
)% |
104,702 |
|
106,826 |
|
(2.0 |
)% |
||||||
|
|
|
|
|
|
|
||||||||||||
PMI Market Share |
|
|
|
|
|
|
||||||||||||
Cigarettes |
30.2 |
% |
31.1 |
% |
(0.9 |
) |
30.2 |
% |
31.5 |
% |
(1.3 |
) |
||||||
Heated Tobacco Units |
8.8 |
% |
7.1 |
% |
1.7 |
|
8.8 |
% |
7.6 |
% |
1.2 |
|
||||||
Total |
39.0 |
% |
38.2 |
% |
0.8 |
|
39.1 |
% |
39.1 |
% |
— |
|
||||||
Note: Sum may not foot due to roundings. |
Second-Quarter
PMI's total cigarette and HTU shipment volume in the Region decreased by 0.5% to 55.4 billion units, mainly due to
PMI's estimated HTU adjusted in-market sales volume in the Region increased by approximately 19.7% in the quarter, reflecting the strong continued growth momentum for IQOS (supported by the further roll-out of ILUMA), including in
PMI's HTU share of the total cigarette and HTU market in the Region increased by 1.7 points, or by 1.6 points on an adjusted basis. Adjusted HTU share for
Six Months Year-to-Date
PMI's total cigarette and HTU shipment volume in the Region decreased by 2.0% to 104.7 billion units, mainly due to
PMI's estimated HTU adjusted in-market sales volume in the Region increased by approximately 21.4% in the first half, including growth in
PMI's HTU share of the total cigarette and HTU market in the Region increased by 1.2 points, or by 1.6 points on an adjusted basis.
Financial Summary
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
3,402 |
|
$ |
3,309 |
|
|
2.8 |
% |
3.1 |
% |
|
93 |
|
(11 |
) |
— |
149 |
(45 |
) |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
1,563 |
|
$ |
1,474 |
|
|
6.0 |
% |
3.9 |
% |
|
89 |
|
31 |
|
— |
149 |
(56 |
) |
(35 |
) |
|||||||
Adjustments (1) |
|
|
(10 |
) |
|
(113 |
) |
|
91.2 |
% |
91.2 |
% |
|
103 |
|
— |
|
— |
— |
— |
|
103 |
|
|||||||
Adjusted Operating Income |
|
$ |
1,573 |
|
$ |
1,587 |
|
|
(0.9 |
)% |
(2.8 |
)% |
|
(14 |
) |
31 |
|
— |
149 |
(56 |
) |
(138 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
46.2 |
% |
|
48.0 |
% |
|
(1.8 |
)pp |
(2.8 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 3.1% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, partly offset by lower HTU (net) pricing (primarily related to the supplemental tax surcharge in
Adjusted operating income decreased by 2.8% on an organic basis, primarily reflecting: higher manufacturing costs (primarily due to inflationary impacts); higher marketing, administration and research costs (primarily due to inflationary impacts); and unfavorable volume/mix, mainly due to the same factors as for net revenues; partly offset by favorable pricing.
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
6,312 |
|
$ |
6,533 |
|
|
(3.4 |
)% |
(0.2 |
)% |
|
(221 |
) |
(208 |
) |
— |
177 |
(190 |
) |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
2,738 |
|
$ |
3,032 |
|
|
(9.7 |
)% |
(7.7 |
)% |
|
(294 |
) |
(60 |
) |
— |
177 |
(236 |
) |
(175 |
) |
|||||||
Adjustments (1) |
|
|
(69 |
) |
|
(165 |
) |
|
58.2 |
% |
58.2 |
% |
|
96 |
|
— |
|
— |
— |
— |
|
96 |
|
|||||||
Adjusted Operating Income |
|
$ |
2,807 |
|
$ |
3,197 |
|
|
(12.2 |
)% |
(10.3 |
)% |
|
(390 |
) |
(60 |
) |
— |
177 |
(236 |
) |
(271 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
44.5 |
% |
|
48.9 |
% |
|
(4.4 |
)pp |
(4.9 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues decreased by 0.2% on an organic basis, reflecting: unfavorable volume/mix, mainly due to lower cigarette volume, as well as unfavorable HTU and cigarette mix, partly offset by higher HTU volume (despite the adverse net impact of estimated wholesaler and distributor HTU inventory movements in
Adjusted operating income decreased by 10.3% on an organic basis, primarily reflecting: unfavorable volume/mix, mainly due to the same factors as for net revenues; higher marketing, administration and research costs (mainly due to inflationary impacts and lower commercial investments in the prior year period); and higher manufacturing costs (primarily due to inflationary impacts); partly offset by the favorable pricing variance.
SSEA, CIS & MEA REGION
Total Market, PMI Shipment & Market Share Commentaries
Second-Quarter
The estimated total market for cigarettes and HTUs in the Region decreased by around 3%, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to
Six Months Year-to-Date
The estimated total market for cigarettes and HTUs in the Region decreased by around 2%, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to
PMI Shipment Volume |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
84,415 |
82,365 |
2.5% |
160,946 |
160,611 |
0.2% |
||||||
Heated Tobacco Units |
5,853 |
5,642 |
3.7% |
11,300 |
10,655 |
6.1% |
||||||
Total SSEA, CIS & MEA |
90,268 |
88,007 |
2.6% |
172,246 |
171,266 |
0.6% |
Second-Quarter
PMI's total cigarette and HTU shipment volume in the Region increased by 2.6% to 90.3 billion units, mainly driven by
Six Months Year-to-Date
PMI's total cigarette and HTU shipment volume in the Region increased by 0.6% to 172.2 billion units, mainly driven by
Financial Summary
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
2,668 |
|
$ |
2,514 |
|
|
6.1 |
% |
14.9 |
% |
|
154 |
|
(221 |
) |
— |
253 |
149 |
|
(27 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
858 |
|
$ |
958 |
|
|
(10.4 |
)% |
(0.2 |
)% |
|
(100 |
) |
(98 |
) |
— |
253 |
(35 |
) |
(220 |
) |
|||||||
Adjustments (1) |
|
|
(5 |
) |
|
(21 |
) |
|
76.2 |
% |
76.2 |
% |
|
16 |
|
— |
|
— |
— |
— |
|
16 |
|
|||||||
Adjusted Operating Income |
|
$ |
863 |
|
$ |
979 |
|
|
(11.8 |
)% |
(1.8 |
)% |
|
(116 |
) |
(98 |
) |
— |
253 |
(35 |
) |
(236 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
32.3 |
% |
|
38.9 |
% |
|
(6.6 |
)pp |
(5.6 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 14.9% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, with HTU pricing also higher; and favorable volume/mix, primarily driven by favorable cigarette mix, as well as higher volume for cigarettes, HTUs and devices.
Adjusted operating income decreased by 1.8% on an organic basis, primarily reflecting: higher manufacturing costs (primarily due to inflationary impacts); higher marketing, administration and research costs; and unfavorable volume/mix, mainly due to cigarettes; partly offset by the favorable pricing variance.
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
5,145 |
|
$ |
4,959 |
|
|
3.8 |
% |
10.4 |
% |
|
186 |
|
(332 |
) |
— |
486 |
185 |
|
(153 |
) |
|||||||
Adjustment (1) |
|
|
(80 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(80 |
) |
— |
|
— |
— |
— |
|
(80 |
) |
|||||||
Adjusted Net Revenues |
|
$ |
5,225 |
|
$ |
4,959 |
|
|
5.4 |
% |
12.1 |
% |
|
266 |
|
(332 |
) |
— |
486 |
185 |
|
(73 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net Revenues |
|
$ |
5,145 |
|
$ |
4,959 |
|
|
3.8 |
% |
10.4 |
% |
|
186 |
|
(332 |
) |
— |
486 |
185 |
|
(153 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
1,570 |
|
$ |
1,923 |
|
|
(18.4 |
)% |
(11.0 |
)% |
|
(353 |
) |
(142 |
) |
— |
486 |
(114 |
) |
(583 |
) |
|||||||
Adjustments (2) |
|
|
(124 |
) |
|
(27 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(97 |
) |
— |
|
— |
— |
— |
|
(97 |
) |
|||||||
Adjusted Operating Income |
|
$ |
1,694 |
|
$ |
1,950 |
|
|
(13.1 |
)% |
(5.8 |
)% |
|
(256 |
) |
(142 |
) |
— |
486 |
(114 |
) |
(486 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
32.4 |
% |
|
39.3 |
% |
|
(6.9 |
)pp |
(6.3 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) Termination of distribution arrangement in the |
||||||||||||||||||||||||||||||
(2) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Adjusted net revenues increased by 12.1% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, with HTU pricing also higher; and favorable volume/mix, primarily driven by favorable cigarette volume/mix, as well as higher volume for HTUs and devices; partly offset by lower fees for certain distribution rights billed to customers in certain markets, shown in "Cost/Other."
Adjusted operating income decreased by 5.8% on an organic basis, primarily reflecting: higher manufacturing costs (primarily due to inflationary impacts); higher marketing, administration and research costs; unfavorable volume/mix, mainly due to cigarettes, partly offset by higher HTU volume; and the impact of lower fees for certain distribution rights, as noted for net revenues; partially offset by the favorable pricing variance.
EA, AU AND PMI DF REGION
Total Market, PMI Shipment & Market Share Commentaries
Second-Quarter
The estimated total market for cigarettes and HTUs in the Region, excluding
Six Months Year-to-Date
The estimated total market for cigarettes and HTUs in the Region, excluding
PMI Shipment Volume |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
13,351 |
14,067 |
(5.1)% |
26,461 |
28,415 |
(6.9)% |
||||||
Heated Tobacco Units |
13,714 |
8,531 |
60.8% |
25,462 |
17,960 |
41.8% |
||||||
Total EA, AU & PMI DF |
27,065 |
22,598 |
19.8% |
51,923 |
46,375 |
12.0% |
Second-Quarter
PMI's total cigarette and HTU shipment volume in the Region increased by 19.8% to 27.1 billion units, mainly driven by
Excluding the net favorable impact of estimated distributor inventory movements (notably driven by cigarettes and HTUs in
Six Months Year-to-Date
PMI's total cigarette and HTU shipment volume in the Region increased by 12.0% to 51.9 billion units, mainly driven by
Excluding the net favorable impact of estimated distributor inventory movements (notably due to HTUs in
Financial Summary
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net Revenues |
|
$ |
1,680 |
|
$ |
1,464 |
|
|
14.8 |
% |
23.8 |
% |
|
216 |
|
(133 |
) |
— |
23 |
326 |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating Income |
|
$ |
544 |
|
$ |
528 |
|
|
3.0 |
% |
27.7 |
% |
|
16 |
|
(130 |
) |
— |
23 |
244 |
(121 |
) |
|||||||
Adjustments (1) |
|
|
(205 |
) |
|
(12 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(193 |
) |
— |
|
— |
— |
— |
(193 |
) |
|||||||
Adjusted Operating Income |
|
$ |
749 |
|
$ |
540 |
|
|
38.7 |
% |
62.8 |
% |
|
209 |
|
(130 |
) |
— |
23 |
244 |
72 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Adjusted Operating Income Margin |
|
|
44.6 |
% |
|
36.9 |
% |
|
7.7 |
pp |
11.6 |
pp |
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 23.8% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume. Pricing variance was favorable, driven by higher cigarette pricing largely offset by lower HTU (net) pricing (primarily related to
Adjusted operating income increased by 62.8% on an organic basis, mainly reflecting: favorable volume/mix, primarily driven by the same factors as for net revenues; and lower supply chain costs.
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net Revenues |
|
$ |
3,200 |
|
$ |
3,051 |
|
|
4.9 |
% |
14.8 |
% |
|
149 |
|
(303 |
) |
— |
37 |
415 |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating Income |
|
$ |
1,167 |
|
$ |
1,213 |
|
|
(3.8 |
)% |
16.4 |
% |
|
(46 |
) |
(245 |
) |
— |
37 |
289 |
(127 |
) |
|||||||
Adjustments (1) |
|
|
(226 |
) |
|
(13 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(213 |
) |
— |
|
— |
— |
— |
(213 |
) |
|||||||
Adjusted Operating Income |
|
$ |
1,393 |
|
$ |
1,226 |
|
|
13.6 |
% |
33.6 |
% |
|
167 |
|
(245 |
) |
— |
37 |
289 |
86 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Adjusted Operating Income Margin |
|
|
43.5 |
% |
|
40.2 |
% |
|
3.3 |
pp |
6.6 |
pp |
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 14.8% on an organic basis, reflecting favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable smoke-free product mix (for HTUs and devices). Pricing variance was favorable, driven by higher cigarette and device pricing largely offset by lower HTU (net) pricing (primarily related to
Adjusted operating income increased by 33.6% on an organic basis, mainly reflecting favorable volume/mix, primarily driven by the same factors as for net revenues, and lower supply chain costs.
Total Market, PMI Shipment & Market Share Commentaries
Second-Quarter
The estimated total market for cigarettes and HTUs in the Region, excluding the
Six Months Year-to-Date
The estimated total market for cigarettes and HTUs in the Region, excluding the
PMI Shipment Volume |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
15,503 |
16,080 |
(3.6)% |
30,413 |
30,875 |
(1.5)% |
||||||
Heated Tobacco Units |
152 |
106 |
43.4% |
254 |
214 |
18.7% |
||||||
Total |
15,655 |
16,186 |
(3.3)% |
30,667 |
31,089 |
(1.4)% |
Second-Quarter
PMI's total cigarette and HTU shipment volume in the Region decreased by 3.3% to 15.7 billion units, mainly due to
Six Months Year-to-Date
PMI's total cigarette and HTU shipment volume in the Region decreased by 1.4% to 30.7 billion units, mainly due to
Financial Summary
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
476 |
|
$ |
469 |
|
|
1.5 |
% |
(1.5 |
)% |
|
7 |
|
14 |
|
— |
36 |
(40 |
) |
(3 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
70 |
|
$ |
130 |
|
|
(46.2 |
)% |
(26.2 |
)% |
|
(60 |
) |
(26 |
) |
— |
36 |
(26 |
) |
(44 |
) |
|||||||
Adjustments (1) |
|
|
(2 |
) |
|
(4 |
) |
|
50.0 |
% |
50.0 |
% |
|
2 |
|
— |
|
— |
— |
— |
|
2 |
|
|||||||
Adjusted Operating Income |
|
$ |
72 |
|
$ |
134 |
|
|
(46.3 |
)% |
(26.9 |
)% |
|
(62 |
) |
(26 |
) |
— |
36 |
(26 |
) |
(46 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
15.1 |
% |
|
28.6 |
% |
|
(13.5 |
)pp |
(7.4 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues decreased by 1.5% on an organic basis, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.
Adjusted operating income decreased by 26.9% on an organic basis, mainly reflecting: higher marketing, administration and research costs (including incremental investments in the
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
921 |
|
$ |
893 |
|
|
3.1 |
% |
0.6 |
% |
|
28 |
|
23 |
|
— |
73 |
(61 |
) |
(7 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
136 |
|
$ |
251 |
|
|
(45.8 |
)% |
(31.5 |
)% |
|
(115 |
) |
(36 |
) |
— |
73 |
(43 |
) |
(109 |
) |
|||||||
Adjustments (1) |
|
|
(9 |
) |
|
(6 |
) |
|
(50.0 |
)% |
(50.0 |
)% |
|
(3 |
) |
— |
|
— |
— |
— |
|
(3 |
) |
|||||||
Adjusted Operating Income |
|
$ |
145 |
|
$ |
257 |
|
|
(43.6 |
)% |
(29.6 |
)% |
|
(112 |
) |
(36 |
) |
— |
73 |
(43 |
) |
(106 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
15.7 |
% |
|
28.8 |
% |
|
(13.1 |
)pp |
(8.6 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 0.6% on an organic basis, primarily reflecting: a favorable pricing variance, driven by higher combustible tobacco pricing; partly offset by unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix.
Adjusted operating income decreased by 29.6% on an organic basis, mainly reflecting: higher marketing, administration and research costs (including incremental investments in the
PMI Shipment Commentary
Swedish Match Oral Product Shipment Volume (1) |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million cans) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Nicotine Pouches |
|
|
|
|
|
|
||||||
|
89.9 |
— |
—% |
163.1 |
— |
—% |
||||||
Scandinavia |
7.5 |
— |
—% |
14.1 |
— |
—% |
||||||
Other |
1.3 |
— |
—% |
2.3 |
— |
—% |
||||||
Total Nicotine Pouches |
98.7 |
— |
—% |
179.5 |
— |
—% |
||||||
|
|
|
|
|
|
|
||||||
Snus |
|
|
|
|
|
|
||||||
Scandinavia |
56.9 |
— |
—% |
107.4 |
— |
—% |
||||||
Other |
1.8 |
— |
—% |
3.8 |
— |
—% |
||||||
Total Snus |
58.7 |
— |
—% |
111.2 |
— |
—% |
||||||
|
|
|
|
|
|
|
||||||
Moist Snuff |
34.1 |
— |
—% |
69.3 |
— |
—% |
||||||
|
|
|
|
|
|
|
||||||
Other |
1.2 |
— |
—% |
2.5 |
— |
—% |
||||||
|
|
|
|
|
|
|
||||||
Total Oral Products |
192.7 |
— |
—% |
362.5 |
— |
—% |
||||||
(1) Excluding |
|
|
|
|
|
|
Volume comparisons versus
Second-Quarter
Nicotine pouch shipment volume increased by 47.5% compared to
Shipment volume for snus declined by 10.2% compared to
Six Months Year-to-Date
Nicotine pouch shipment volume increased by 45.4% compared to
Shipment volume for snus declined by 12.9% compared to
Swedish Match Combustible Product Shipment Volume |
Second-Quarter |
Six Months Year-to-Date |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigars |
430.3 |
— |
—% |
907.1 |
— |
—% |
Second-Quarter
Cigar shipment volume declined by 6.0% compared to
Six Months Year-to-Date
Cigar shipment volume declined by 0.9% compared to
Financial Summary
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net Revenues |
|
$ |
665 |
|
$ |
— |
|
— |
% |
— |
% |
|
665 |
|
— |
665 |
|
— |
— |
— |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Operating Income |
|
$ |
264 |
|
$ |
— |
|
— |
% |
— |
% |
|
264 |
|
— |
264 |
|
— |
— |
— |
|||||||
Adjustments (1) |
|
|
(49 |
) |
|
— |
|
— |
% |
— |
% |
|
(49 |
) |
— |
(49 |
) |
— |
— |
— |
|||||||
Adjusted Operating Income |
|
$ |
313 |
|
$ |
— |
|
— |
% |
— |
% |
|
313 |
|
— |
313 |
|
— |
— |
— |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Adjusted Operating Income Margin |
|
|
47.1 |
% |
|
n/a |
|
— |
pp |
— |
pp |
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
PMI recorded net revenues of
PMI recorded adjusted operating income of
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net Revenues |
|
$ |
1,246 |
|
$ |
— |
|
— |
% |
— |
% |
|
1,246 |
|
— |
1,246 |
|
— |
— |
— |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Operating Income |
|
$ |
457 |
|
$ |
— |
|
— |
% |
— |
% |
|
457 |
|
— |
457 |
|
— |
— |
— |
|||||||
Adjustments (1) |
|
|
(117 |
) |
|
— |
|
— |
% |
— |
% |
|
(117 |
) |
— |
(117 |
) |
— |
— |
— |
|||||||
Adjusted Operating Income |
|
$ |
574 |
|
$ |
— |
|
— |
% |
— |
% |
|
574 |
|
— |
574 |
|
— |
— |
— |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Adjusted Operating Income Margin |
|
|
46.1 |
% |
|
n/a |
|
— |
pp |
— |
pp |
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
PMI recorded net revenues of
PMI recorded adjusted operating income of
WELLNESS AND HEALTHCARE
The operating results of PMI’s Vectura Fertin Pharma business are reported in the Wellness and Healthcare segment.
Financial Summary
Second-Quarter
Quarters Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
76 |
|
$ |
76 |
|
|
— |
% |
— |
% |
|
— |
|
— |
|
— |
(2 |
) |
— |
2 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income / (Loss) |
|
$ |
(733 |
) |
$ |
(34 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(699 |
) |
(3 |
) |
— |
(2 |
) |
— |
(694 |
) |
|||||||
Adjustments (1) |
|
|
(695 |
) |
|
(18 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(677 |
) |
— |
|
— |
— |
|
— |
(677 |
) |
|||||||
Adjusted Operating Income / (Loss) |
|
$ |
(38 |
) |
$ |
(16 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(22 |
) |
(3 |
) |
— |
(2 |
) |
— |
(17 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income / (Loss) Margin |
|
|
(50.0 |
)% |
|
(21.1 |
)% |
|
(28.9 |
)pp |
(25.0 |
)pp |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues were flat on an organic basis, notably reflecting higher net revenues for smoking cessation products, offset by the unfavorable impact of phasing for select inhalation products.
The adjusted operating loss of
Six Months Year-to-Date
Six Months Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net Revenues |
|
$ |
162 |
|
$ |
142 |
|
|
14.1 |
% |
17.6 |
% |
|
20 |
|
(5 |
) |
— |
23 |
— |
2 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating Income / (Loss) |
|
$ |
(771 |
) |
$ |
(65 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(706 |
) |
(2 |
) |
— |
23 |
— |
(727 |
) |
|||||||
Adjustments (1) |
|
|
(709 |
) |
|
(37 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(672 |
) |
— |
|
— |
— |
— |
(672 |
) |
|||||||
Adjusted Operating Income / (Loss) |
|
$ |
(62 |
) |
$ |
(28 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(34 |
) |
(2 |
) |
— |
23 |
— |
(55 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Adjusted Operating Income / (Loss) Margin |
|
|
(38.3 |
)% |
|
(19.7 |
)% |
|
(18.6 |
)pp |
(16.2 |
)pp |
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 17.6% on an organic basis, notably driven by the favorable impact of phasing for select inhalation products (notably in the first quarter), coupled with higher net revenues for smoking cessation products.
The adjusted operating loss of
Forward-Looking and Cautionary Statements
This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; and business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.
PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of
PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended
Non-GAAP Measures and Reconciliations to Non-GAAP Measures
Reconciliations of non-GAAP measures in this release to the most directly comparable
Management reviews net revenues, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and other special items. Additionally, starting in 2022 and on a comparative basis, for these measures other than net revenues and operating cash flow, PMI includes adjustments to add back amortization expense on acquisition related intangible assets that are recorded as part of purchase accounting and contribute to PMI’s revenue generation, as well as impairment of intangible assets, if any. Currency-neutral and organic growth rates reflect the way management views underlying performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI’s business performance between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of management.
Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix 1 |
|
|
|||||||||||||||||||||||||
Key Market Data |
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended |
|||||||||||||||||||||||||
Market |
|
Total Market, bio units |
|
PMI Shipments, bio units |
|
PMI Market Share,% (2) |
|||||||||||||||||||
|
|
Total |
|
Cigarette |
|
HTU |
|
Total |
|
HTU |
|||||||||||||||
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
pp |
|
2023 |
2022 |
pp |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (1) (2) |
|
649.9 |
663.7 |
(2.1) |
|
188.4 |
182.5 |
3.3 |
|
157.0 |
157.7 |
(0.4) |
|
31.4 |
24.8 |
26.6 |
|
28.5 |
27.4 |
1.1 |
|
4.6 |
3.9 |
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
7.6 |
8.5 |
(10.4) |
|
3.7 |
3.8 |
(1.3) |
|
3.7 |
3.7 |
(1.4) |
|
0.1 |
0.1 |
7.9 |
|
42.4 |
42.8 |
(0.4) |
|
0.8 |
0.7 |
0.1 |
|
|
|
17.9 |
18.0 |
(0.5) |
|
6.9 |
7.0 |
(1.7) |
|
6.1 |
6.5 |
(6.2) |
|
0.7 |
0.5 |
62.8 |
|
39.2 |
38.7 |
0.5 |
|
5.4 |
3.9 |
1.5 |
|
|
|
18.4 |
18.8 |
(2.2) |
|
9.8 |
10.9 |
(10.2) |
|
7.0 |
7.8 |
(10.4) |
|
2.8 |
3.1 |
(9.7) |
|
53.6 |
54.0 |
(0.4) |
|
17.0 |
14.4 |
2.6 |
|
|
|
15.0 |
14.8 |
1.4 |
|
6.1 |
5.6 |
8.5 |
|
4.9 |
4.5 |
8.0 |
|
1.2 |
1.1 |
10.4 |
|
40.6 |
37.9 |
2.7 |
|
8.2 |
7.5 |
0.7 |
|
|
|
11.3 |
11.5 |
(2.3) |
|
3.6 |
3.7 |
(3.4) |
|
3.3 |
3.5 |
(4.3) |
|
0.3 |
0.2 |
9.9 |
|
29.2 |
30.1 |
(0.9) |
|
2.2 |
1.7 |
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SSEA, CIS & MEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
16.1 |
22.5 |
(28.7) |
|
6.0 |
4.9 |
23.2 |
|
5.7 |
4.7 |
21.5 |
|
0.3 |
0.2 |
66.1 |
|
37.2 |
23.1 |
14.1 |
|
1.8 |
0.8 |
1.0 |
|
|
|
72.0 |
75.6 |
(4.7) |
|
20.8 |
21.4 |
(2.5) |
|
20.8 |
21.4 |
(2.5) |
|
— |
— |
— |
|
28.9 |
28.3 |
0.6 |
|
— |
— |
— |
|
|
|
10.0 |
11.2 |
(10.5) |
|
5.7 |
7.1 |
(19.8) |
|
5.6 |
7.0 |
(20.0) |
|
— |
— |
— |
|
56.5 |
63.1 |
(6.6) |
|
0.5 |
0.4 |
0.1 |
|
|
|
53.0 |
54.6 |
(3.0) |
|
16.5 |
16.8 |
(1.7) |
|
12.6 |
12.9 |
(2.1) |
|
3.9 |
3.9 |
(0.3) |
|
32.1 |
30.5 |
1.6 |
|
7.7 |
6.9 |
0.8 |
|
|
|
36.1 |
31.6 |
14.4 |
|
18.5 |
14.5 |
27.6 |
|
18.5 |
14.5 |
27.6 |
|
— |
— |
— |
|
51.3 |
46.0 |
5.3 |
|
— |
— |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EA, AU & PMI DF |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
1.9 |
2.3 |
(15.3) |
|
0.6 |
0.7 |
(13.5) |
|
0.6 |
0.7 |
(13.5) |
|
— |
— |
— |
|
32.5 |
31.9 |
0.6 |
|
— |
— |
— |
|
|
|
37.5 |
37.5 |
0.1 |
|
16.7 |
12.0 |
38.7 |
|
4.9 |
5.1 |
(3.2) |
|
11.8 |
7.0 |
69.2 |
|
39.4 |
37.3 |
2.1 |
|
26.4 |
23.0 |
3.4 |
|
|
|
18.5 |
18.7 |
(1.1) |
|
3.6 |
3.6 |
1.9 |
|
2.3 |
2.4 |
(5.5) |
|
1.3 |
1.1 |
18.1 |
|
19.5 |
19.0 |
0.5 |
|
7.0 |
5.9 |
1.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
7.3 |
7.3 |
(0.1) |
|
4.5 |
4.7 |
(4.3) |
|
4.5 |
4.7 |
(4.3) |
|
— |
— |
— |
|
61.6 |
64.3 |
(2.7) |
|
— |
— |
— |
|
|
|
7.4 |
8.0 |
(7.6) |
|
4.6 |
5.2 |
(10.2) |
|
4.6 |
5.1 |
(10.2) |
|
— |
— |
— |
|
63.0 |
64.8 |
(1.8) |
|
0.4 |
0.4 |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Market share estimates are calculated using IMS data, unless otherwise stated |
|||||||||||||||||||||||||
(2) Total market and market share estimates include cigarillos in |
|||||||||||||||||||||||||
(3) PMI market share reflects estimated adjusted in-market sales volume share. Historical HTU adjusted in-market sales volume share: Q3, 2022 (3.7%); Q4, 2022 (4.7%); Q1, 2023 (5.4%). Historical total adjusted in-market sales volume share: Q3, 2022 (38.3%); Q4, 2022 (39.7%); Q1, 2023 (39.4%) |
|||||||||||||||||||||||||
Note:% change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix 2 |
|||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
Key Market Data |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Six Months Ended |
||||||||||||||||||||||||||||||||||||
Market |
Total Market, bio units |
PMI Shipments, bio units |
PMI Market Share,%(2) |
|||||||||||||||||||||||||||||||||
Total |
Cigarette |
HTU |
Total |
HTU |
||||||||||||||||||||||||||||||||
2023 |
|
2022 |
|
% |
|
2023 |
|
2022 |
|
% |
|
2023 |
|
2022 |
|
% |
|
2023 |
|
2022 |
|
% |
|
2023 |
|
2022 |
|
pp |
|
2023 |
|
2022 |
|
pp |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Total (1) (2) |
1,265.4 |
1,276.4 |
(0.9) |
359.5 |
355.6 |
1.1 |
300.7 |
305.9 |
(1.7) |
58.8 |
49.6 |
18.5 |
27.9 |
27.4 |
0.5 |
4.6 |
4.0 |
0.6 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
15.1 |
16.3 |
(7.3) |
7.5 |
7.3 |
2.8 |
7.4 |
7.2 |
2.6 |
0.1 |
0.1 |
15.5 |
42.3 |
43.8 |
(1.5) |
0.8 |
0.7 |
0.1 |
||||||||||||||||||
|
33.7 |
34.0 |
(0.9) |
12.9 |
13.8 |
(6.3) |
11.6 |
12.4 |
(6.1) |
1.3 |
1.4 |
(8.5) |
39.3 |
38.9 |
0.4 |
5.4 |
3.9 |
1.5 |
||||||||||||||||||
|
35.6 |
35.6 |
— |
18.7 |
20.7 |
(9.5) |
13.9 |
14.9 |
(6.8) |
4.8 |
5.7 |
(16.6) |
53.8 |
54.1 |
(0.3) |
17.2 |
14.6 |
2.6 |
||||||||||||||||||
|
28.5 |
27.5 |
3.3 |
11.6 |
10.4 |
11.8 |
9.2 |
8.3 |
10.2 |
2.5 |
2.1 |
18.1 |
40.8 |
37.7 |
3.1 |
8.6 |
7.5 |
1.1 |
||||||||||||||||||
|
21.2 |
21.6 |
(2.0) |
6.5 |
7.0 |
(8.3) |
6.0 |
6.6 |
(9.3) |
0.4 |
0.4 |
8.7 |
29.1 |
30.2 |
(1.1) |
2.2 |
1.6 |
0.6 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
SSEA, CIS & MEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
38.5 |
46.0 |
(16.3) |
11.7 |
10.2 |
15.0 |
11.3 |
9.9 |
14.2 |
0.5 |
0.3 |
37.9 |
30.4 |
22.5 |
7.9 |
1.4 |
0.8 |
0.6 |
||||||||||||||||||
|
141.1 |
149.5 |
(5.6) |
40.5 |
42.3 |
(4.1) |
40.5 |
42.3 |
(4.1) |
— |
— |
— |
28.7 |
28.3 |
0.4 |
— |
— |
— |
||||||||||||||||||
|
21.3 |
26.5 |
(19.7) |
12.3 |
16.7 |
(26.3) |
12.2 |
16.6 |
(26.6) |
0.1 |
0.1 |
17.7 |
57.8 |
63.0 |
(5.2) |
0.5 |
0.3 |
0.2 |
||||||||||||||||||
|
97.9 |
100.3 |
(2.4) |
31.2 |
30.9 |
1.0 |
23.5 |
23.6 |
(0.4) |
7.7 |
7.3 |
5.4 |
31.7 |
30.5 |
1.2 |
8.0 |
7.7 |
0.3 |
||||||||||||||||||
|
62.3 |
55.5 |
12.4 |
31.3 |
25.5 |
22.7 |
31.3 |
25.5 |
22.7 |
— |
— |
— |
50.3 |
46.1 |
4.2 |
— |
— |
— |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
EA, AU & PMI DF |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
3.8 |
4.5 |
(14.9) |
1.3 |
1.5 |
(11.6) |
1.3 |
1.5 |
(11.6) |
— |
— |
— |
34.2 |
32.9 |
1.3 |
— |
— |
— |
||||||||||||||||||
|
72.9 |
71.9 |
1.4 |
31.5 |
26.3 |
19.8 |
9.6 |
11.2 |
(14.4) |
21.9 |
15.1 |
45.2 |
39.5 |
37.2 |
2.3 |
26.3 |
23.0 |
3.3 |
||||||||||||||||||
|
35.4 |
35.6 |
(0.4) |
6.9 |
6.8 |
1.1 |
4.4 |
4.6 |
(4.4) |
2.5 |
2.2 |
12.6 |
19.5 |
19.3 |
0.2 |
6.9 |
6.2 |
0.7 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
15.0 |
14.9 |
0.6 |
9.4 |
9.6 |
(2.5) |
9.4 |
9.6 |
(2.5) |
— |
— |
— |
62.3 |
64.3 |
(2.0) |
— |
— |
— |
||||||||||||||||||
|
13.5 |
14.5 |
(6.8) |
8.3 |
9.2 |
(9.8) |
8.3 |
9.2 |
(9.8) |
0.1 |
0.1 |
2.3 |
61.9 |
63.9 |
(2.0) |
0.4 |
0.4 |
— |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
(1) Market share estimates are calculated using IMS data, unless otherwise stated |
||||||||||||||||||||||||||||||||||||
(2) Total market and market share estimates include cigarillos in |
||||||||||||||||||||||||||||||||||||
(3) PMI market share reflects estimated adjusted in-market sales volume share |
||||||||||||||||||||||||||||||||||||
Note:% change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230719235864/en/
Investor Relations:
Lausanne: +41 (0)58 242 4666
InvestorRelations@pmi.com
Media:
Lausanne: +41 (0)58 242 4500
David.Fraser@pmi.com
Source: